RDZN vs. GOCO, FANH, EHTH, FFIC, PPT, RRBI, HIVE, RBB, BRT, and BWB
Should you be buying Roadzen stock or one of its competitors? The main competitors of Roadzen include GoHealth (GOCO), Fanhua (FANH), eHealth (EHTH), Flushing Financial (FFIC), Putnam Premier Income Trust (PPT), Red River Bancshares (RRBI), HIVE Digital Technologies (HIVE), RBB Bancorp (RBB), BRT Apartments (BRT), and Bridgewater Bancshares (BWB). These companies are all part of the "finance" sector.
GoHealth (NASDAQ:GOCO) and Roadzen (NASDAQ:RDZN) are both small-cap finance companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, media sentiment, risk, analyst recommendations, earnings, community ranking, institutional ownership, valuation and dividends.
24.2% of GoHealth shares are owned by institutional investors. Comparatively, 24.7% of Roadzen shares are owned by institutional investors. 52.0% of GoHealth shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
GoHealth has a beta of 1.75, suggesting that its stock price is 75% more volatile than the S&P 500. Comparatively, Roadzen has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500.
Roadzen has lower revenue, but higher earnings than GoHealth.
In the previous week, GoHealth had 1 more articles in the media than Roadzen. MarketBeat recorded 2 mentions for GoHealth and 1 mentions for Roadzen. Roadzen's average media sentiment score of 0.00 equaled GoHealth'saverage media sentiment score.
GoHealth received 39 more outperform votes than Roadzen when rated by MarketBeat users.
Roadzen has a net margin of 0.00% compared to Roadzen's net margin of -8.61%. GoHealth's return on equity of 0.00% beat Roadzen's return on equity.
GoHealth presently has a consensus target price of $13.00, indicating a potential upside of 28.08%. Given Roadzen's higher possible upside, equities research analysts plainly believe GoHealth is more favorable than Roadzen.
Summary
GoHealth beats Roadzen on 6 of the 10 factors compared between the two stocks.
Get Roadzen News Delivered to You Automatically
Sign up to receive the latest news and ratings for RDZN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding RDZN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
